Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2019 Filed Feb 5, 2019 23:43 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Tax withholdingCommon Stock | 1,492 | $119.86 | $178,831.12 |
DisclosureSEC source: 0000059478-19-000032 · wf-form4_154941021277393.xml · nonDerivative · entry 2 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,409 Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:43 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Exercise / conversionCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000032 · wf-form4_154941021277393.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:49 UTC |
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSA
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000034 · wf-form4_154941055968100.xml · derivative · entry 4 Conterno Enrique A · CIK 0001476151 · SVP&Pres, LillyDiab & LillyUSA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,222 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:49 UTC |
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSA
|
Tax withholdingCommon Stock | 5,476 | $119.86 | $656,353.36 |
DisclosureSEC source: 0000059478-19-000034 · wf-form4_154941055968100.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · SVP&Pres, LillyDiab & LillyUSA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,280 Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:49 UTC |
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSA
|
Exercise / conversionCommon Stock | 12,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000034 · wf-form4_154941055968100.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · SVP&Pres, LillyDiab & LillyUSA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:55 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000036 · wf-form4_154941093289519.xml · derivative · entry 4 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,889 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:55 UTC |
Fry Stephen FSVP, HR & Diversity
|
Tax withholdingCommon Stock | 3,995 | $119.86 | $478,840.70 |
DisclosureSEC source: 0000059478-19-000036 · wf-form4_154941093289519.xml · nonDerivative · entry 2 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,105 Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:55 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionCommon Stock | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000036 · wf-form4_154941093289519.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:59 UTC |
Harrington Michael JSenior VP and General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000038 · wf-form4_154941114595606.xml · derivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,778 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:59 UTC |
Harrington Michael JSenior VP and General Counsel
|
Tax withholdingCommon Stock | 4,404 | $119.86 | $527,863.44 |
DisclosureSEC source: 0000059478-19-000038 · wf-form4_154941114595606.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,144 Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:59 UTC |
Harrington Michael JSenior VP and General Counsel
|
Exercise / conversionCommon Stock | 12,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000038 · wf-form4_154941114595606.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 6, 2019 00:04 UTC |
Ricks David ADirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000040 · wf-form4_154941143494674.xml · derivative · entry 4 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,222 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 6, 2019 00:04 UTC |
Ricks David ADirector · President & CEO
|
Tax withholdingCommon Stock | 5,485 | $119.86 | $657,432.10 |
DisclosureSEC source: 0000059478-19-000040 · wf-form4_154941143494674.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,223 Read SEC document |
| February 01, 2019 Filed Feb 6, 2019 00:04 UTC |
Ricks David ADirector · President & CEO
|
Exercise / conversionCommon Stock | 12,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000040 · wf-form4_154941143494674.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 6, 2019 00:09 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000042 · wf-form4_154941175147496.xml · derivative · entry 4 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,722 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 6, 2019 00:09 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
Tax withholdingCommon Stock | 4,364 | $119.86 | $523,069.04 |
DisclosureSEC source: 0000059478-19-000042 · wf-form4_154941175147496.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,582 Read SEC document |
| February 01, 2019 Filed Feb 6, 2019 00:09 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
Exercise / conversionCommon Stock | 9,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000042 · wf-form4_154941175147496.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 7, 2019 01:10 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000073 · wf-form4_154950181957323.xml · derivative · entry 7 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 0 Underlying: Common Stock · 3,221 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 7, 2019 01:10 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
Tax withholdingCommon Stock | 1,491 | $119.86 | $178,711.26 |
DisclosureSEC source: 0000059478-19-000073 · wf-form4_154950181957323.xml · nonDerivative · entry 2 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 52,684 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| February 01, 2019 Filed Feb 7, 2019 01:10 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
Exercise / conversionCommon Stock | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000073 · wf-form4_154950181957323.xml · nonDerivative · entry 1 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 54,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:32 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 4,000 | $120.00 | $480,000.00 |
DisclosureSEC source: 0000059478-19-000028 · wf-form4_154931592950395.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,224 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2018. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:07 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 93 | $117.09 | $10,889.37 |
DisclosureSEC source: 0000059478-19-000002 · wf-form4_154837124193431.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,373 Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:14 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 91 | $117.09 | $10,655.19 |
DisclosureSEC source: 0000059478-19-000004 · wf-form4_154837163948667.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,207 Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:19 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 58 | $117.09 | $6,791.22 |
DisclosureSEC source: 0000059478-19-000006 · wf-form4_154837196046203.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,200 Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:26 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 17 | $117.09 | $1,990.53 |
DisclosureSEC source: 0000059478-19-000008 · wf-form4_154837234447146.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,847 Read SEC document |
| January 22, 2019 Filed Jan 25, 2019 01:40 UTC |
Walker KarenDirector
|
GrantCommon Stock | 85 | $117.09 | $9,952.65 |
DisclosureSEC source: 0000059478-19-000010 · wf-form4_154838044008818.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211 Read SEC document |
| January 17, 2019 Filed Jan 18, 2019 18:14 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,444 | $118.84 | $4,925,122.07 |
DisclosureSEC source: 0001209191-19-004484 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,825,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.60 to $119.13, inclusive. Read SEC document |
| January 17, 2019 Filed Jan 18, 2019 18:14 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 95,133 | $118.11 | $11,236,158.63 |
DisclosureSEC source: 0001209191-19-004484 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,866,748 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.60 to $118.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 18:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,657 | $117.87 | $195,314.73 |
DisclosureSEC source: 0001209191-19-004116 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,961,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.60 to $118.03, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 19:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 51,766 | $117.74 | $6,095,135.90 |
DisclosureSEC source: 0001209191-19-003906 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,963,538 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.60 to $118.03, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:51 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 89 | $108.36 | $9,644.04 |
DisclosureSEC source: 0000059478-18-000297 · wf-form4_154525266128080.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114 Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:53 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 50 | $108.36 | $5,418.00 |
DisclosureSEC source: 0000059478-18-000299 · wf-form4_154525281867329.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,694 Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:58 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 101 | $108.36 | $10,944.36 |
DisclosureSEC source: 0000059478-18-000301 · wf-form4_154525309499570.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,278 Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:09 UTC |
Walker KarenDirector
|
GrantCommon Stock | 126 | $115.81 | $14,592.06 |
DisclosureSEC source: 0000059478-18-000304 · wf-form4_154525373680051.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 20:15 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
SaleCommon Stock | 5,700 | $113.59 | $647,463.00 |
DisclosureSEC source: 0000059478-18-000290 · wf-form4_154464569083766.xml · nonDerivative · entry 2 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 50,954 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $113.45 to $113.60. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 20:15 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
SaleCommon Stock | 19,300 | $112.72 | $2,175,496.00 |
DisclosureSEC source: 0000059478-18-000290 · wf-form4_154464569083766.xml · nonDerivative · entry 1 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 56,654 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $112.37 to $113.34. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 20:43 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,500 | $119.00 | $1,844,535.65 |
DisclosureSEC source: 0001209191-18-061219 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,015,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.70 to $119.465, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 02, 2018 Filed Dec 4, 2018 20:14 UTC |
White Anne E.SVP & Pres-Lilly Oncology
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000286 · wf-form4_154395442914579.xml · derivative · entry 3 White Anne E. · CIK 0001752313 · SVP & Pres-Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2018-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| December 02, 2018 Filed Dec 4, 2018 20:14 UTC |
White Anne E.SVP & Pres-Lilly Oncology
|
Tax withholdingCommon Stock | 3,306 | $118.64 | $392,223.84 |
DisclosureSEC source: 0000059478-18-000286 · wf-form4_154395442914579.xml · nonDerivative · entry 2 White Anne E. · CIK 0001752313 · SVP & Pres-Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,797 Read SEC document |
| December 02, 2018 Filed Dec 4, 2018 20:14 UTC |
White Anne E.SVP & Pres-Lilly Oncology
|
Exercise / conversionCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000286 · wf-form4_154395442914579.xml · nonDerivative · entry 1 White Anne E. · CIK 0001752313 · SVP & Pres-Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 16:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 600 | $117.89 | $70,734.00 |
DisclosureSEC source: 0001209191-18-060331 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,030,804 F2 · price: These shares were sold at a price of $117.89 as reported in Column 4. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 16:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 184,400 | $117.42 | $21,651,694.80 |
DisclosureSEC source: 0001209191-18-060331 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,031,404 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.89 to $117.87, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 15:55 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 190,000 | $115.57 | $21,957,939.00 |
DisclosureSEC source: 0001209191-18-060187 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,215,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.40 to $115.82, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:16 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 1,605 | $115.81 | $185,875.05 |
DisclosureSEC source: 0000059478-18-000262 · wf-form4_154275219717054.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,096 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:19 UTC |
Bertozzi Carolyn RDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000264 · wf-form4_154275237201466.xml · nonDerivative · entry 1 Bertozzi Carolyn R · CIK 0001698766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,307 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:27 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000266 · wf-form4_154275281789804.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,235 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:32 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 1,558 | $115.81 | $180,431.98 |
DisclosureSEC source: 0000059478-18-000268 · wf-form4_154275313920891.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,441 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:37 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000270 · wf-form4_154275341805799.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,282 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:41 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 1,594 | $115.81 | $184,601.14 |
DisclosureSEC source: 0000059478-18-000272 · wf-form4_154275365158652.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,102 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:44 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000274 · wf-form4_154275387386317.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,908 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.